Citius Oncology (CTOR) Cash from Financing Activities (2023 - 2026)
Citius Oncology (CTOR) posted quarterly Cash from Financing Activities of -$231199.0 for Q1 2026, down 101.53% quarter-over-quarter from $15.1 million in Q4 2025.
Citius Oncology (CTOR) Cash from Financing Activities (2023 - 2026) Analysis & Trends
Citius Oncology (CTOR) has reported Cash from Financing Activities for 4 consecutive years, with -$231199.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Financing Activities changed N/A year-over-year to -$231199.0; the TTM figure through Mar 2026 stood at -$9.4 million (changed N/A YoY), while the FY2025 annual figure was $15.2 million, up 211.19% from the prior year.
- Cash from Financing Activities eased to -$231199.0 in Q1 2026 per CTOR's latest filing, from $15.1 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $15.1 million in Q4 2025 and bottomed at -$24.5 million in Q1 2024.
- Historically, Cash from Financing Activities has averaged -$1.7 million across 4 years, with a median of $264393.0 in 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | -1.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -813.00 Mn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -1.13 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 122.40 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -1.24 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 63.40 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | -74.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Citius Oncology | 81.99 Mn | 81.99 Mn | 1.00 Mn | 18.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -231,199.00 |
| Mar 31, 2026 | -231,199.00 |
| Dec 31, 2025 | 15.13 Mn |
| Dec 31, 2025 | 15.13 Mn |
| Jun 30, 2024 | 264,393.00 |
| Jun 30, 2024 | 264,393.00 |
| Mar 31, 2024 | -24.55 Mn |
| Mar 31, 2024 | -24.55 Mn |
| Sep 30, 2023 | 779,875.00 |
| Sep 30, 2023 | 779,875.00 |